Moreover, while we observed that markers such as EPCAM and ERBB2 were downregulated in CRC, further research is required to clarify the impact of inflammatory responses, such as leukocytosis, on the detectability of circulating RNA in patients with CRC. The gene discussed is EPCAM; the disease is colorectal carcinoma.